Our Consultants

Home/Our Consultants
Our Consultants 2016-11-15T12:19:51+00:00

Our Consultants

MD, FRCS (Urol) Eng

Alex studied medicine at the University of Leicester before subsequently training in Urology in the East Midlands. She then headed to Toronto for two years to undertake further specialist training in urological oncology obtaining membership of the American Society of Urologic Oncology. She was appointed as a Consultant Urologist at Addenbrooke’s Hospital in Cambridge in 2011 and has a specialist interest in the treatment of bladder cancer.

Along with Bill Turner and Ben Thomas, Alex is one of three members of the Bladder Oncology Team at Addenbrooke’s that specialises in the management of high-risk bladder cancer. This includes use of a number of non-surgical approaches (eg intravesical BCG therapy) as well as to radical surgery to remove the bladder and a full range of reconstructive urinary diversion techniques, including neobladder formation.

Alex’s interest in the management of bladder cancer has seen her involvement as a committee member for both the 2012 International Consultation on Urological Diseases consultation on Bladder Cancer (http://www.icud.info/bladdercancer2nd.html) and also the NHS Shared Decision Making project creating a patient decision aid for patients with bladder cancer (http://sdm.rightcare.nhs.uk/pda). Alex is the current chair of the Addenbrooke’s Special Multidisciplinary team that meets on a weekly basis to discuss patients from the Anglia region who have recently been diagnosed with a urological cancer. She is also the lead for the Addenbrooke’s Haematuria clinic, a service that specialises in rapid assessment of patients who see blood in their urine. In addition to her interest in bladder cancer Alex maintains a general urology practice assessing and treating patients with a wide range of urological problems including difficulties urinating and urinary tract infections.

PhD, FRCS (Urol)

Vincent’s interest in urology began in medical school. He trained in one of the premier units in the country (Newcastle upon Tyne) in this specialty. After graduating he became an anatomy instructor and surgical trainee in the Northern surgical rotation. During this time he developed a strong research interest in prostate cancer and completed a PhD in cancer biology in 2002. He then trained in both surgical and academic urology in the North East as a Specialist Registrar and Clinician Scientist. In 2007 he undertook a fellowship training in minimally invasive/robotic prostatectomy at St Joseph’s Hospital, Paris..

In 2008 Vincent took up his role as Consultant Urological Surgeon and University Lecturer in Cambridge. He currently combines clinical and academic work in the Department of Urology, Addenbrookes Hospital and the University of Cambridge. His current clinical practice includes all aspects of general urology as well as specialist work in prostatic diseases and prostate cancer. His major research interest is in the field of prostate cancer and in the translation of laboratory findings to clinical practice. He currently leads an active translational and clinical research programme in prostate cancer which is very closely linked to his urological practice. He has been chair and committee member for numerous regional and national committees and panels as well as leads the urology R&D trials team in Cambridge.

Vincent believes that effective communication is essential to help ensure that patients get the best care and are well informed. This is particularly important when discussing the complexities of prostate cancer or indeed many other urological conditions. He offers clinical consultation in general urology and a specific service in prostate cancer diagnostics (image guided) and risk stratified management.

Click here to listen to Vincent being interviewed on prostate cancer by CRUK and other interview links:

Vincent’s research and work has been high-lighted in the press and media on a number of occasions:

He is the recipient of numerous prizes and awards including the Urological Research Society Prize, Hunterian Professorship of the Royal College of Surgeons, the CE Alken prize and a Health Enterprise East Innovation Award. He is also visiting Professor at Anglia Ruskin University.

MD FRCS (Urol)

Sami is a consultant urologist at Addenbrookes’ Hospital in Cambridge and at Hinchingbrooke’ Hospital in Huntington. He has admitting rights to the Spire Cambridge Lea, Cambridge Nuffield and Melberry Huntington hospitals. He has special expertise in treating kidney stones (laser, keyhole surgery and shockwave lithotripsy), diagnosing and endoscopically managing ureteric and kidney urethelial cancer, managing male and female lower urinary tract disorders (due to enlarged prostate or bladder dysfunction), recurrent urinary tract infections, pelvic pain and chronic prostatitis. He was trained in robotic surgery for kidney and prostate cancer. He has a special interest in sexual dysfunction in addition to his skills in managing all aspects of general benign and cancer urology conditions. Sami had formal training as an expert witness.

Sami has joined St Georges’ Hospital Medical School and received his primary medical qualification from London University. He completed his basic surgical training in Yorkshire. Having a curious mind and an academic interest, he undertook over two-year research fellowship at the Bristol Urological Institute with world experts in the field of lower urinary dysfunction, incontinence and urodynamics. His research led to several publications and was awarded the Doctor of Medicine (MD) degree from London University. Sami has gained broad experience in General Urology by joining the Southwest of England Specialist Registrar higher surgical training program in Urology, which is one of the most competitive in the country.

Sami was then appointed as a clinical instructor in Urology in the United State of America (USA). During a busy year at the University of Pittsburgh Medical Centre, Cleveland Clinic and the Arthur Smith Institute of Urology in New York. he developed special expertise in all aspects of Endourology treating all types of urinary stones (with laser, keyhole surgery and shockwave lithotripsy) and endoscopic treatment of upper tract urothelial cancer. He was also trained in advanced minimally invasive urology techniques including laparoscopic and robotic surgery to treat kidney and prostate cancer.

Being organised and a team player led Sami to take on several management and leadership roles: he is currently the UK board member for the International Young Urologist Association (IYUA) and the local champion of the British Association of Urological Surgeons (BAUS) for Cambridge University. He has also acted as the UK trainees’ representative on the board of the European Society of Residents in Urology (ESRU), the Senior Urology Registrars Group (SURG) representative on the Andrology executive committee for BAUS, a member of the International Continence Society Ethics Committee and a representative for the British Medical Association (BMA). He is an active member of the Royal College of Surgeons of England, the European Association of Urology (EAU) and the American Urological Association (AUA) in addition to the British Association of Urological Surgeons (BAUS).

Sami enjoys training future doctors and urologists and has special interest in education and research. He is currently the lead for Cambridge University medical students. He contributes, as a faculty, to training courses for national and international residents and established young urologists. He has been invited as an expert speaker to local, national and international meetings. His hard work was recognized with numerous prizes and awards. As an acknowledgement of his achievements, he was included in the 5th and 6th editions of “Marquis Who’s Who in Medicine and Healthcare” and was nominated for “The Man of the Year in Medicine and Healthcare” in 2010.

Sami has contributed to literature with a number of book chapters and published several articles relating to kidney stones, bladder and prostate cancer in addition to bladder and prostate urinary symptoms. He acts as a reviewer for several high impact medical journals.

In his practice, Sami recognizes the threefold professional duty to treat, learn and teach focusing on safe patients’ journey and ensuring that high quality healthcare remains his main priority at all times. He believes that treatment should be individualized and tailored to patient’s preference in the context of up to date scientific evidence. Some publications listed below:


Al-Hayek S and Averch T.: The Role of Pre-Stenting for Ureteroscopy. In: Monga M, editor. Ureteroscopy: Indications, Instrumentation and Technique. 1st ed. Springer. In Press

Al-Hayek S. Urinary Tract Infection. In: Probert J, editor. An Atlas of Investigation and Diagnosis Urology. 1st ed. Oxford: Clinical Publishing; 2009. p. 9-23

Al-Hayek S, Abrams P. Clinical Diagnosis of Overactive Bladder. In: Raz S, Rodriguez LV, editors. Female Urology. 3rd ed. Philadelphia: Saunders Elsevier; 2008. p. 197-203

Al-Hayek S, Abrams P. The Standardization of Terminology of Lower Urinary Tract Function Recommended by the ICS. In: Cardozo L, Staskin D, editors. Textbook of Female Urology & Urogynegology. 2nd ed. Oxfordshire: Informa Healthcare; 2006. p. 759-70


Al-Hayek S, Jackman SV and Averch TD. The impact of obesity on urine composition and nephrolithiasis management. J Endourol. 2013 Mar;27(3):379-83

Yan X, Al-Hayek S, Gan W, Zhu W, Li X, Guo H. Minimally invasive percutaneous nephrolithotomy in preschool age children with kidney calculi (including stones induced by melamine-contaminated milk powder). Pediatr Surg Int. 2012 Oct;28(10):1021-4

Yan X, Zhu Z, Zhu W, Huang H, Al-Hayek S, Guo H. Photodynamic Effect of 5-aminolevulinic Acid (5-ALA)-loaded Nanoparticles on Bladder Cancer Cells: a Preliminary Investigation. Scand J Urol. 2013 Apr;47(2):145-51

Al-Hayek S and Abrams P. The fifty-year history of the ice water test in urology. J Urol. 2010 May; 183(5): 1686-92

Abdul-Rahman A, Al-Hayek S and Belal M. Urodynamic studies in the evaluation of the older man with lower urinary tract symptoms: when, which ones, and what to do with the results. Therapeutic Advances in Urology 2010; 2 (5-6): 187-194

Al-Hayek S and Abrams P. Cystometry and overactive bladder: The need for provocative testing. Current Bladder Dysfunction Reports 2009; 4(4): 181-239

Al-Hayek S, Belal M, Abrams P. Does the patient’s position influence the detection of detrusor overactivity? Neurourol Urodyn 2008; 27(4): 279-86

Boddy JL, Pike DJ, Al-Hayek S, Shaida N, Malone PR. An elevated PSA, which normalizes, does not exclude the presence of prostate cancer. Prostate Cancer Prostatic Dis 2005; 8(4): 349-52

Al-Hayek S and Abrams P. Incontinence in the elderly. Women’s Health Medicine 2005; 2(6): 46-50

Al-Hayek S and Abrams P. Stress incontinence, why it occurs? Women’s Health Medicine 2005; 2(6): 26-8

Al-Hayek S, Thomas A, Abrams P. Natural history of detrusor contractility–minimum ten-year urodynamic follow-up in men with bladder outlet obstruction and those with detrusor underactivity. Scand J Urol Nephrol Suppl 2004; (215): 101-8

Al-Hayek S and Abrams P. Women’s lower urinary tract function and dysfunction: definitions and epidemiology. Minerva Ginecol 2004 Aug; 56(4): 311-25


With medicine running in the family, Nikesh entered medical school at St. Bartholomew’s Hospital Medical College in London. Whilst at Bart’s Nikesh completed a BSc in Psychology. He then undertook basic surgical training at St. Bartholomew’s, the Royal London Hospital, Ipswich Hospital and Great Ormond Street Hospital, London. After a period of research at Great Ormond Street and the Institute of Urology, UCL, Nikesh was awarded an MD by the University of London for his investigation into the normal and abnormal developing bladder. Advanced urological training followed in Wessex, providing an excellent grounding in all aspects of general urology.

Nikesh then enjoyed a very valuable year as Senior Fellow in Perth, Australia, gaining clinical and management experience, running a very busy urological service. In his early years as a consultant, his expertise has been further developed through collaboration with leading units in London, Sheffield, and in Dallas and North Carolina, U.S.

At Addenbrookes Hospital, Cambridge Univeristy Hospitals NHS Trust, Nikesh is the clinical lead in his long-standing specialist area of interest, bladder dysfunction, incontinence, reconstruction and urethral stricture disease and has been Clinical Lead for Urology at Hinchingbrooke Hospital.

Nikesh is audit lead and an elected committee member of the Female, Neurological and Urodynamic section of the British Association of Urology (http://www.baus.org.uk/Sections/female/) and invited member of the European Association of Urology sections of Female and Functional Urology (http://www.uroweb.org/sections/new-female-and-functional-urology-esffu/) and Young Academic Urologists.

Nikesh has given invited lectures and been on faculty for international meetings including Leading Lights in Urology, Challenge the Experts, ESFFU section meetings and British Association of Urology and European Association of Urology Annual Meetings. Maintaining his interest in teaching, Nikesh has organised courses including the Cambridge Pelvic Floor Symposium and Update in Urodynamics meetings. Click here to listen to an interview with Nikesh outlining his plenary session lecture on Urinary Catheters at the European Association of Urology in Stockholm in 2014. A further interview with Nikesh discussing the new Urolift device for the treatment of male lower urinary tract symptoms can be viewed here.

As an expert in incontinence and reconstruction, Nikesh has contributed to NICE consultations, NHS Horizon Scanning documents (http://www.hsc.nihr.ac.uk/diseases/new-and-emerging-technologies-for-urinary-and-faec/), NICE Eyes on Evidence (report available here) and Design for Dignity discussions. He has co-authored NHS England documents on improving continence care (https://www.england.nhs.uk/commissioning/home-2/continence/). He has contributed to the European Association of Urology Patient Information sheets (accessed here). He reviews articles for leading international urological journals and National Institute for Health Research and as principal investigator, runs a number of commercial and national research trials at Addenbrookes Hospital.

MD, FRCS (Urol)

Bill studied Medicine in Cambridge and Oxford, and trained in Surgery and Urology in Oxford, Switzerland and Yorkshire. He trained broadly in general urology, and has specialist training in the management of incontinence and the management of bladder cancer. He has been a Consultant Urologist at Addenbrooke’s Hospital since 1999, with specialist practice in bladder cancer (including radical surgery) and in female and reconstructive urology.

Bill is one of the three member Cambridge team for the management of high risk bladder cancer, along with colleagues Alex Colquhoun and Ben Thomas, based at Addenbrooke’s Hospital. He has extensive experience of bladder cancer, including management with BCG vaccine or with surgical removal of the bladder (cystectomy). He led the development of the service in Cambridge that allows patients who have cystectomy to be offered the options of a urinary stoma (ileal conduit), or reconstruction of the urinary tract, using either bladder substitution or a catheterisable reservoir.

He also has extensive experience of general urology, including the management of suspected bladder cancer, in patients who notice blood in their urine (hamaturia).
Bill has a strong interest in clinical guideline development. He is clinical lead in the NICE Bladder Cancer Guideline Development Group, and has been a member of a NICE Technology Appraisal Committee, the NICE Male Lower Urinary Tract Symptoms Guideline Development Group (http://publications.nice.org.uk/lower-urinary-tract-symptoms-cg97), the European Association of Urology Incontinence Guideline Group (http://www.uroweb.org/gls/pdf/18_Urinary_Incontinence_LR_1 October 2012.pdf), and a member of three committees in the 2012 International Consultation on Urological Diseases consultation on Bladder Cancer (http://www.icud.info/bladdercancer2nd.html).
During his time at Addenbrooke’s, he has been Service Director for Urology for four years. He has chaired the local and specialist Urology cancer multidisciplinary teams, and co-chaired the Urology group of the Anglia Cancer Network. He was also Programme Director for Higher Urology Training for the Eastern Deanery for five years and is a member of the University of Cambridge Clinical School Communication Skills Team.

He has an interest in medical ethics and law, and has had formal training as an expert witness. He has been a member of the Cambridgeshire 2 Research Ethics Committee.